Edition:
United Kingdom

Kazia Therapeutics Ltd (KZIA.OQ)

KZIA.OQ on NASDAQ Stock Exchange Capital Market

3.57USD
17 Aug 2018
Change (% chg)

$0.11 (+3.18%)
Prev Close
$3.46
Open
$3.49
Day's High
$3.57
Day's Low
$3.49
Volume
700
Avg. Vol
4,566
52-wk High
$6.64
52-wk Low
$2.28

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec 0.07 0.009
FY 2017 Jun '17 0.11 -0.134
Dec 0.14 -0.092
FY 2016 Jun '16 0.24 -0.192
Dec 0.17 -0.090
 
*Note: Units in Millions ofAustralian Dollars
**Note: Units in Australian Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.64 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -0.08 0.93 0.89
Price to Sales (TTM) 79.63 114.98 5.75
Price to Book (MRQ) 0.18 15.51 5.00
Price to Tangible Book (MRQ) 2.10 14.52 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 1.59 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -55.57 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago -38.66 80.50 5.64
Sales - 5 Yr. Growth Rate -29.68 32.27 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 82.47 29.15 20.60
EPS (TTM) vs TTM 1 Yr. Ago 55.28 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate 63.40 40.43 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 3.62 5.53 3.03
LT Debt to Equity (MRQ) 0.00 35.26 12.51
Total Debt to Equity (MRQ) 0.00 37.08 16.85
Interest Coverage (TTM) -381,217.00 -102.44 32.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.17 54.37
Gross Margin - 5 Yr. Avg. -- 50.57 52.17
EBITD Margin (TTM) -6,924.99 -- --
EBITD - 5 Yr. Avg -2,506.94 -603.21 10.65
Operating Margin (TTM) -7,495.51 -759.76 4.32
Operating Margin - 5 Yr. Avg. -2,718.78 -625.13 6.06
Pre-Tax Margin (TTM) -4,367.83 -733.60 5.18
Pre-Tax Margin - 5 Yr. Avg. -2,028.72 -628.46 6.49
Net Profit Margin (TTM) -4,288.05 -734.98 1.48
Net Profit Margin - 5 Yr. Avg. -2,018.50 -631.51 2.77
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,229,989 860,375,103
Net Income/Employee (TTM) -- 3,144,143 101,207,184
Receivable Turnover (TTM) 0.11 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.01 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -29.88 -0.16 11.13
Return on Assets - 5 Yr. Avg. -34.24 3.50 12.40
Return on Investment (TTM) -33.03 1.78 14.61
Return on Investment - 5 Yr. Avg. -38.70 2.55 16.13
Return on Equity (TTM) -36.01 3.28 16.33
Return on Equity - 5 Yr. Avg. -39.42 3.42 17.39
  1 Year 3 Year 5 Year
Sales % -38.66 42.12 -29.68
EPS (TTM) % 79.79 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kazia Therapeutics Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.22%
# of Holders: 8
Total Shares Held: 107,398
3 Mo. Net Change: 12,751
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 0
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.